|
Insider Trading: AMYLIN PHARMACEUTICALS INC , Part 2
Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of AMYLIN PHARMACEUTICALS INC in the last 24 months are illustrated in figures 1 and 2. Table 1 shows the monthly insider trading data of AMYLIN PHARMACEUTICALS INC since year 2005. (See page 1 of this report.) Table 2 shows the detailed insider transactions of AMYLIN PHARMACEUTICALS INC since 2005.
The reporting company's ticker symbol is AMLN.
The reporting company's CIK number is 881464.
The total value of stock buying since 2005 is $166,931,749.
The total value of stock sales is $72,155,307.
The total value of stock exercises is $8,052,588.
1 year stock price chart,
1 day stock price chart
opopp opopopop
Figure 1. Monthly insider transaction values at AMYLIN PHARMACEUTICALS INC (AMLN) in the past 24 months.
The trade values of insider stock buys, sales, and option exercises are in logarithmic scale
as shown on the right axis labels.
The detailed monthly and daily insider transactions are listed in the 2 tables below.
08 09 10 11 12 01 2007 02 03 04 05 06 07 08 09 10 11 12 01 2008 02 03 04 05 06 07 -
Figure 2. Average prices of insider buys, sales, and option exercises at AMYLIN PHARMACEUTICALS INC (AMLN) in the past 24 months. See table 2 for insider transaction details.
08 09 10 11 12 01 2007 02 03 04 05 06 07 08 09 10 11 12 01 2008 02 03 04 05 06 07 -
Go to page: 1
2
3
4
Table 2. Detailed insider stock purchases, sales, and option exercises
for AMYLIN PHARMACEUTICALS INC (AMLN) , Part 2
| Trade Date |
Insider Name |
Trade Type |
Shares |
Price ($) |
Value ($) |
| 2007-08-06 | Graham Ginger L (Executive Advisor) | Sale | 10,000 | 49.50 | 495,013 |
| 2007-08-06 | Graham Ginger L (Executive Advisor) | Option Exercise | 10,000 | 4.38 | 43,750 |
| 2007-08-06 | Greene Howard E Jr (Director) | Sale | 3,846 | 48.67 | 187,189 |
| 2007-08-02 | Cook Joseph C Jr (Director) | Sale | 100 | 46.63 | 4,663 |
| 2007-08-01 | Gergen Mark J (Sr VP, Corporate Development) | Sale | 500 | 46.50 | 23,250 |
| 2007-08-01 | Gergen Mark J (Sr VP, Corporate Development) | Option Exercise | 500 | 16.80 | 8,400 |
| 2007-08-01 | Rowland Lloyd A (VP, Gov/Compliance, Secretary) | Sale | 2,000 | 46.31 | 92,622 |
| 2007-08-01 | Rowland Lloyd A (VP, Gov/Compliance, Secretary) | Option Exercise | 2,000 | 18.85 | 37,700 |
| 2007-08-01 | Kolterman Orville G (Sr VP Clinical and Regulatory) | Sale | 1,700 | 46.50 | 79,050 |
| 2007-08-01 | Kolterman Orville G (Sr VP Clinical and Regulatory) | Option Exercise | 1,700 | 9.62 | 16,362 |
| 2007-08-01 | Eberhard Craig A (VP Sales) | Sale | 2,000 | 46.31 | 92,622 |
| 2007-08-01 | Eberhard Craig A (VP Sales) | Option Exercise | 2,000 | 18.85 | 37,700 |
| 2007-08-01 | Baron Alain D (Sr VP Research) | Sale | 3,000 | 46.50 | 139,500 |
| 2007-08-01 | Baron Alain D (Sr VP Research) | Option Exercise | 3,000 | 7.19 | 21,562 |
| 2007-08-01 | Cook Joseph C Jr (Director) | Sale | 9,900 | 46.54 | 460,731 |
| 2007-07-31 | Foletta Mark G (Senior VP, Finance & CFO) | Sale | 3,500 | 47.43 | 166,022 |
| 2007-07-31 | Foletta Mark G (Senior VP, Finance & CFO) | Option Exercise | 3,500 | 13.25 | 46,375 |
| 2007-07-27 | Cook Joseph C Jr (Director) | Option Exercise | 140,000 | 2.66 | 371,840 |
| 2007-07-24 | Gergen Mark J (Sr VP, Corporate Development) | Sale | 500 | 45.00 | 22,500 |
| 2007-07-24 | Gergen Mark J (Sr VP, Corporate Development) | Option Exercise | 500 | 16.80 | 8,400 |
| 2007-07-24 | Baron Alain D (Sr VP Research) | Sale | 2,000 | 45.50 | 91,000 |
| 2007-07-24 | Baron Alain D (Sr VP Research) | Option Exercise | 2,000 | 9.57 | 19,137 |
| 2007-07-23 | Greene Howard E Jr (Director) | Sale | 3,846 | 43.34 | 166,699 |
| 2007-07-18 | Baron Alain D (Sr VP Research) | Sale | 1,000 | 43.18 | 43,180 |
| 2007-07-18 | Baron Alain D (Sr VP Research) | Option Exercise | 1,000 | 11.95 | 11,950 |
| 2007-07-17 | Cook Joseph C Jr (Director) | Sale | 10,000 | 42.96 | 429,616 |
| 2007-07-16 | Kolterman Orville G (Sr VP Clinical and Regulatory) | Sale | 6,700 | 43.69 | 292,705 |
| 2007-07-16 | Kolterman Orville G (Sr VP Clinical and Regulatory) | Option Exercise | 6,700 | 8.42 | 56,391 |
| 2007-07-12 | Baron Alain D (Sr VP Research) | Sale | 2,000 | 43.00 | 86,000 |
| 2007-07-12 | Baron Alain D (Sr VP Research) | Option Exercise | 2,000 | 7.19 | 14,375 |
| 2007-07-09 | Greene Howard E Jr (Director) | Sale | 3,846 | 42.33 | 162,804 |
| 2007-07-03 | Cook Joseph C Jr (Director) | Sale | 10,000 | 41.92 | 419,189 |
| 2007-07-02 | Gergen Mark J (Sr VP, Corporate Development) | Sale | 500 | 41.20 | 20,600 |
| 2007-07-02 | Gergen Mark J (Sr VP, Corporate Development) | Option Exercise | 500 | 16.80 | 8,400 |
| 2007-07-02 | Rowland Lloyd A (VP, Gov/Compliance, Secretary) | Sale | 2,000 | 41.00 | 82,000 |
| 2007-07-02 | Rowland Lloyd A (VP, Gov/Compliance, Secretary) | Option Exercise | 2,000 | 18.85 | 37,700 |
| 2007-07-02 | Kolterman Orville G (Sr VP Clinical and Regulatory) | Sale | 5,000 | 41.16 | 205,809 |
| 2007-07-02 | Kolterman Orville G (Sr VP Clinical and Regulatory) | Option Exercise | 5,000 | 1.61 | 8,047 |
| 2007-06-29 | Foletta Mark G (Senior VP, Finance & CFO) | Sale | 2,500 | 41.38 | 103,455 |
| 2007-06-29 | Foletta Mark G (Senior VP, Finance & CFO) | Option Exercise | 2,500 | 13.25 | 33,125 |
| 2007-06-25 | Greene Howard E Jr (Director) | Sale | 3,846 | 41.34 | 158,991 |
| 2007-06-18 | Baron Alain D (Sr VP Research) | Sale | 1,000 | 42.97 | 42,970 |
| 2007-06-18 | Baron Alain D (Sr VP Research) | Option Exercise | 1,000 | 9.62 | 9,625 |
| 2007-06-15 | Kolterman Orville G (Sr VP Clinical and Regulatory) | Sale | 6,700 | 42.99 | 288,031 |
| 2007-06-15 | Kolterman Orville G (Sr VP Clinical and Regulatory) | Option Exercise | 6,700 | 7.81 | 52,343 |
| 2007-06-12 | Graham Ginger L (Executive Advisor) | Option Exercise | 2,898 | 23.00 | 66,654 |
| 2007-06-11 | Greene Howard E Jr (Director) | Sale | 3,846 | 41.46 | 159,472 |
| 2007-06-04 | Cook Joseph C Jr (Director) | Sale | 10,000 | 44.77 | 447,656 |
| 2007-06-01 | Gergen Mark J (Sr VP, Corporate Development) | Sale | 1,000 | 46.16 | 46,160 |
| 2007-06-01 | Gergen Mark J (Sr VP, Corporate Development) | Option Exercise | 1,000 | 16.80 | 16,800 |
| 2007-06-01 | Rowland Lloyd A (VP, Gov/Compliance, Secretary) | Sale | 2,000 | 46.64 | 93,280 |
| 2007-06-01 | Rowland Lloyd A (VP, Gov/Compliance, Secretary) | Option Exercise | 2,000 | 18.85 | 37,700 |
| 2007-06-01 | Kolterman Orville G (Sr VP Clinical and Regulatory) | Sale | 5,000 | 46.12 | 230,615 |
| 2007-06-01 | Kolterman Orville G (Sr VP Clinical and Regulatory) | Option Exercise | 5,000 | .31 | 1,565 |
| 2007-06-01 | Eberhard Craig A (VP Sales) | Sale | 2,000 | 46.00 | 91,999 |
| 2007-06-01 | Eberhard Craig A (VP Sales) | Option Exercise | 2,000 | 18.85 | 37,700 |
| 2007-06-01 | Baron Alain D (Sr VP Research) | Sale | 4,000 | 46.16 | 184,640 |
| 2007-06-01 | Baron Alain D (Sr VP Research) | Option Exercise | 4,000 | 9.06 | 36,255 |
| 2007-06-01 | Testman Thomas R (Director) | Sale | 12,000 | 46.62 | 559,382 |
| 2007-06-01 | Testman Thomas R (Director) | Option Exercise | 12,000 | 16.23 | 194,760 |
| 2007-05-31 | Foletta Mark G (Senior VP, Finance & CFO) | Sale | 6,500 | 45.79 | 297,662 |
| 2007-05-31 | Foletta Mark G (Senior VP, Finance & CFO) | Option Exercise | 6,500 | 13.25 | 86,125 |
| 2007-05-31 | Wilson James N (Director) | Sale | 2,166 | 46.24 | 100,155 |
| 2007-05-30 | Baron Alain D (Sr VP Research) | Sale | 1,000 | 46.00 | 46,000 |
| 2007-05-30 | Baron Alain D (Sr VP Research) | Option Exercise | 1,000 | 11.95 | 11,950 |
| 2007-05-29 | Greene Howard E Jr (Director) | Sale | 3,846 | 45.20 | 173,831 |
| 2007-05-25 | Testman Thomas R (Director) | Sale | 20,000 | 44.88 | 897,606 |
| 2007-05-25 | Testman Thomas R (Director) | Option Exercise | 20,000 | 16.99 | 339,799 |
| 2007-05-22 | Wilson James N (Director) | Sale | 500 | 45.52 | 22,760 |
| 2007-05-21 | Gergen Mark J (Sr VP, Corporate Development) | Sale | 500 | 45.00 | 22,500 |
| 2007-05-21 | Gergen Mark J (Sr VP, Corporate Development) | Option Exercise | 500 | 16.80 | 8,400 |
| 2007-05-21 | Baron Alain D (Sr VP Research) | Sale | 1,000 | 45.00 | 45,000 |
| 2007-05-21 | Baron Alain D (Sr VP Research) | Option Exercise | 1,000 | 10.94 | 10,940 |
| 2007-05-21 | Wilson James N (Director) | Sale | 2,166 | 44.80 | 97,036 |
| 2007-05-17 | Cook Joseph C Jr (Director) | Sale | 10,000 | 42.52 | 425,177 |
| 2007-05-16 | Baron Alain D (Sr VP Research) | Sale | 1,000 | 42.29 | 42,290 |
| 2007-05-16 | Baron Alain D (Sr VP Research) | Option Exercise | 1,000 | 7.19 | 7,187 |
| 2007-05-15 | Kolterman Orville G (Sr VP Clinical and Regulatory) | Sale | 6,700 | 42.29 | 283,335 |
| 2007-05-15 | Kolterman Orville G (Sr VP Clinical and Regulatory) | Option Exercise | 6,700 | 2.03 | 13,607 |
| 2007-05-14 | Baron Alain D (Sr VP Research) | Sale | 2,000 | 43.00 | 86,000 |
| 2007-05-14 | Baron Alain D (Sr VP Research) | Option Exercise | 2,000 | 11.95 | 23,900 |
| 2007-05-14 | Greene Howard E Jr (Director) | Sale | 3,846 | 42.90 | 165,011 |
| 2007-05-07 | Bradbury Daniel (President & Chief Exec Officer) | Sale | 2,894 | 41.90 | 121,258 |
| 2007-05-02 | Cook Joseph C Jr (Director) | Sale | 10,000 | 42.07 | 420,704 |
| 2007-05-01 | Gergen Mark J (Sr VP, Corporate Development) | Sale | 500 | 41.25 | 20,625 |
| 2007-05-01 | Gergen Mark J (Sr VP, Corporate Development) | Option Exercise | 500 | 16.80 | 8,400 |
| 2007-05-01 | Rowland Lloyd A (VP, Gov/Compliance, Secretary) | Sale | 5,000 | 41.50 | 207,500 |
| 2007-05-01 | Rowland Lloyd A (VP, Gov/Compliance, Secretary) | Option Exercise | 5,000 | 11.95 | 59,750 |
| 2007-05-01 | Kolterman Orville G (Sr VP Clinical and Regulatory) | Sale | 5,000 | 41.12 | 205,583 |
| 2007-05-01 | Kolterman Orville G (Sr VP Clinical and Regulatory) | Option Exercise | 5,000 | .31 | 1,565 |
| 2007-04-30 | Foletta Mark G (Senior VP, Finance & CFO) | Sale | 2,500 | 42.32 | 105,800 |
| 2007-04-30 | Foletta Mark G (Senior VP, Finance & CFO) | Option Exercise | 2,500 | 13.25 | 33,125 |
| 2007-04-30 | Greene Howard E Jr (Director) | Sale | 3,846 | 42.09 | 161,890 |
| 2007-04-27 | Baron Alain D (Sr VP Research) | Sale | 2,000 | 43.00 | 86,000 |
| 2007-04-27 | Baron Alain D (Sr VP Research) | Option Exercise | 2,000 | 11.95 | 23,900 |
| 2007-04-18 | Cook Joseph C Jr (Director) | Sale | 10,000 | 41.94 | 419,375 |
| 2007-04-16 | Kolterman Orville G (Sr VP Clinical and Regulatory) | Sale | 6,700 | 40.58 | 271,862 |
| 2007-04-16 | Kolterman Orville G (Sr VP Clinical and Regulatory) | Option Exercise | 6,700 | .55 | 3,664 |
| 2007-04-16 | Baron Alain D (Sr VP Research) | Sale | 1,000 | 40.55 | 40,550 |
| 2007-04-16 | Baron Alain D (Sr VP Research) | Option Exercise | 1,000 | 5.73 | 5,730 |
| 2007-04-16 | Greene Howard E Jr (Director) | Sale | 3,846 | 41.46 | 159,445 |
| 2007-04-13 | Kolterman Orville G (Sr VP Clinical and Regulatory) | Sale | 5,000 | 40.06 | 200,300 |
| 2007-04-13 | Kolterman Orville G (Sr VP Clinical and Regulatory) | Option Exercise | 5,000 | 2.91 | 14,530 |
| 2007-04-13 | Baron Alain D (Sr VP Research) | Sale | 1,000 | 40.06 | 40,060 |
| 2007-04-13 | Baron Alain D (Sr VP Research) | Option Exercise | 1,000 | 5.73 | 5,730 |
| 2007-04-09 | Bradbury Daniel (President & Chief Exec Officer) | Sale | 2,500 | 38.66 | 96,657 |
| 2007-04-04 | Cook Joseph C Jr (Director) | Sale | 10,000 | 37.94 | 379,447 |
| 2007-04-02 | Gergen Mark J (Sr VP, Corporate Development) | Sale | 500 | 37.47 | 18,735 |
| 2007-04-02 | Gergen Mark J (Sr VP, Corporate Development) | Option Exercise | 500 | 16.80 | 8,400 |
| 2007-04-02 | Rowland Lloyd A (VP Legal & General Counsel) | Sale | 2,000 | 36.95 | 73,901 |
| 2007-04-02 | Rowland Lloyd A (VP Legal & General Counsel) | Option Exercise | 2,000 | 11.95 | 23,900 |
| 2007-04-02 | Greene Howard E Jr (Director) | Sale | 3,846 | 37.12 | 142,778 |
| 2007-03-30 | Foletta Mark G (Senior VP, Finance & CFO) | Sale | 2,500 | 37.61 | 94,025 |
| 2007-03-30 | Foletta Mark G (Senior VP, Finance & CFO) | Option Exercise | 2,500 | 13.25 | 33,125 |
| 2007-03-22 | Bradbury Daniel (President & Chief Operating) | Option Exercise | 39,269 | 10.49 | 411,905 |
| 2007-03-19 | Cook Joseph C Jr (Director) | Sale | 10,000 | 37.71 | 377,149 |
| 2007-03-19 | Greene Howard E Jr (Director) | Sale | 3,846 | 37.71 | 145,048 |
| 2007-03-15 | Kolterman Orville G (Sr VP Clinical and Regulatory) | Sale | 6,700 | 38.20 | 255,930 |
| 2007-03-15 | Kolterman Orville G (Sr VP Clinical and Regulatory) | Option Exercise | 6,700 | .78 | 5,232 |
| 2007-03-07 | Bradbury Daniel (President & Chief Operating) | Sale | 2,500 | 37.00 | 92,500 |
| 2007-03-05 | Cook Joseph C Jr (Director) | Sale | 10,000 | 37.20 | 371,950 |
| 2007-03-05 | Greene Howard E Jr (Director) | Sale | 3,846 | 37.20 | 143,071 |
| 2007-03-01 | Gergen Mark J (Sr VP, Corporate Development) | Sale | 500 | 37.75 | 18,875 |
| 2007-03-01 | Gergen Mark J (Sr VP, Corporate Development) | Option Exercise | 500 | 16.80 | 8,400 |
| 2007-03-01 | Rowland Lloyd A (VP Legal & General Counsel) | Sale | 2,000 | 37.39 | 74,772 |
| 2007-03-01 | Rowland Lloyd A (VP Legal & General Counsel) | Option Exercise | 2,000 | 11.95 | 23,900 |
| 2007-02-28 | Foletta Mark G (Senior VP, Finance & CFO) | Sale | 2,500 | 38.82 | 97,050 |
| 2007-02-28 | Foletta Mark G (Senior VP, Finance & CFO) | Option Exercise | 2,500 | 12.60 | 31,500 |
| 2007-02-20 | Greene Howard E Jr (Director) | Sale | 3,846 | 40.49 | 155,710 |
| 2007-02-15 | Kolterman Orville G (Sr VP Clinical and Regulatory) | Sale | 6,700 | 40.23 | 269,551 |
| 2007-02-15 | Kolterman Orville G (Sr VP Clinical and Regulatory) | Option Exercise | 6,700 | .78 | 5,232 |
| 2007-02-07 | Bradbury Daniel (President & Chief Operating) | Sale | 3,500 | 40.52 | 141,820 |
| 2007-02-05 | Greene Howard E Jr (Director) | Sale | 3,846 | 39.63 | 152,406 |
| 2007-02-01 | Gergen Mark J (Sr VP, Corporate Development) | Sale | 500 | 38.75 | 19,375 |
| 2007-02-01 | Gergen Mark J (Sr VP, Corporate Development) | Option Exercise | 500 | 16.80 | 8,400 |
| 2007-02-01 | Rowland Lloyd A (VP Legal & General Counsel) | Sale | 2,000 | 38.92 | 77,840 |
| 2007-02-01 | Rowland Lloyd A (VP Legal & General Counsel) | Option Exercise | 2,000 | 11.95 | 23,900 |
| 2007-02-01 | Kolterman Orville G (Sr VP Clinical and Regulatory) | Sale | 5,000 | 38.69 | 193,426 |
| 2007-02-01 | Kolterman Orville G (Sr VP Clinical and Regulatory) | Option Exercise | 5,000 | 14.38 | 71,875 |
| 2007-01-31 | Foletta Mark G (Senior VP, Finance & CFO) | Sale | 2,500 | 39.00 | 97,500 |
| 2007-01-31 | Foletta Mark G (Senior VP, Finance & CFO) | Option Exercise | 2,500 | 11.95 | 29,875 |
| 2007-01-22 | Greene Howard E Jr (Director) | Sale | 3,846 | 39.55 | 152,103 |
| 2007-01-16 | Kolterman Orville G (Sr VP Clinical and Regulatory) | Sale | 5,000 | 41.54 | 207,712 |
| 2007-01-16 | Kolterman Orville G (Sr VP Clinical and Regulatory) | Option Exercise | 5,000 | .78 | 3,905 |
| 2007-01-11 | Kolterman Orville G (Sr VP Clinical and Regulatory) | Sale | 5,000 | 40.00 | 200,000 |
| 2007-01-11 | Kolterman Orville G (Sr VP Clinical and Regulatory) | Option Exercise | 5,000 | 3.28 | 16,405 |
| 2007-01-09 | Bradbury Daniel (President & Chief Operating) | Sale | 2,500 | 38.51 | 96,276 |
| 2007-01-08 | Greene Howard E Jr (Director) | Sale | 3,846 | 38.16 | 146,761 |
| 2007-01-03 | Gergen Mark J (Sr VP, Corporate Development) | Sale | 500 | 36.29 | 18,145 |
| 2007-01-03 | Gergen Mark J (Sr VP, Corporate Development) | Option Exercise | 500 | 16.80 | 8,400 |
Go to page: 1
2
3
4
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above tables cannot be completely guaranteed as to their accuracy.
For more insider trading information of AMYLIN PHARMACEUTICALS INC (symbol AMLN,
CIK number 881464) see
the Securities and Exchange Commission (SEC) website.
|
|
